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Abstract 
Objective 
Medicaid and Children’s Health Insurance Program (CHIP) plans publicly report quality 
measures including follow-up care after psychiatric hospitalization. We aimed to understand 
failure to meet this measure, including measurement definitions and enrollee characteristics, 
while investigating how follow-up affects subsequent psychiatric hospitalizations and emergency 
department (ED) visits. 
Methods 
Administrative data representing Alabama’s CHIP from 2013-2016 were used to identify 
qualifying psychiatric hospitalizations and follow-up care with a mental health provider within 7 
and 30 days of discharge. Using relaxed measure definitions, follow-up care was extended to 
include visits at 45 to 60 days and visits to a primary care provider. Logit regressions estimated 
enrollee characteristics associated with follow-up care and, separately, the likelihood of 
subsequent psychiatric hospitalizations/ED visits within 30, 60, and 120 days.  
Results 
We observed 1,072 psychiatric hospitalizations during the study period. Of these, 356 (33.2%) 
received follow-up within 7 days and 566 (52.8%) within 30 days. Relaxed measure definitions 
captured minimal additional follow-up visits. The likelihood of follow-up was lower at both 7 (-
18 percentage points [pp], 95% confidence interval [CI] -26 pp– -10 pp) and 30 days (-26 pp, 
95% CI -35 pp– -17 pp)) for hospitalization stays of ≥8 days. Meeting the measure reduced the 
likelihood of subsequent psychiatric hospitalizations within 60 days by 3 pp (95% CI -6 pp– -1 
pp). 
Conclusions 
Among children, receipt of timely follow-up care after a psychiatric hospitalization is low, and 
not sensitive to measurement definitions. Follow-up care may reduce the need of future 
psychiatric hospitalizations/ED visits. 
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Psychiatric conditions including major depressive, bipolar, behavioral, and mood disorders are 
common among children and adolescents. Approximately 20% of children and adolescents in the 
United States have a psychiatric condition.1-3 Particularly concerning is that half of adolescents 
between ages 13-18 years will be treated for a psychiatric condition by the age of 18, including 
22% with severe impairment.4 One condition alone, major depressive events with severe 
impairment, affected 9.4% of 12-17 year old adolescents in 2017, increasing 71% from 2007.5 
Approximately 10% of hospitalizations and emergency department (ED) visits among children 
and adolescents have psychiatric primary diagnoses, approximately 20% of all hospitalizations 
have psychiatric comorbidities, and the evidence suggests prevalence and utilization are 
increasing.6-8 The direct and indirect costs to treat and manage these conditions is estimated over 
$247 billion annually.2 Furthermore, psychiatric conditions are common among children with 
excessively high health expenditures, known as “super-utilizers.”9  
Optimal management of psychiatric conditions is necessary for improving 
outcomes and reducing health care costs. Psychiatric readmissions and ED visits are most 
frequent within the first 30 to 90 days after an initial psychiatric hospitalization and may 
be associated with inadequate follow-up care.10-12 Ideally, all children acute psychiatric 
hospitalizations will receive appropriate counseling, attentive management of 
prescription medications, and timely follow-up care to ensure a successful transition back 
into the community. Medicaid and State Children’s Health Insurance Program (CHIP) 
agencies voluntarily report compliance with this standard of care as part of the Centers 
for Medicare and Medicaid Services (CMS) Child Core Set.13 Specifically, Follow-Up 
After Hospitalization for Mental Illness (FUH), is a quality measure designed to identify 
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the percentage of children who received follow-up care from a mental health provider within 7 
and 30 days from discharge.  
State-reported data demonstrates considerable variation in follow-up care after 
psychiatric hospitalization, ranging from 14.4% to 75.6% within 7 days and 28.7% to 91.0% 
within 30 days.14 Previous research associated follow-up care with age, race, geographic setting, 
and clinical conditions.15-17 However, prior studies have not examined whether poor measure 
performance is related to measure definitions or whether measure performance impacts acute 
downstream health service utilization. 
Empirical evaluations of this quality measure are limited and therefore barriers to follow-
up care, the existence of racial/geographic disparities, or the benefits are not well-characterized. 
The purpose of this study was to evaluate the measure FUH with three objectives. First, we 
described the components of the measure children most often fail to meet, including care 
received after 30 days from a someone other than a qualified mental health provider or at all. 
Second, we identified the characteristics of children associated with the likelihood of meeting the 
measure, including demographic, geographic, and hospitalizations characteristics. Finally, we 
assessed the extent to which subsequent hospitalizations and ED visits are associated with receipt 
of timely follow-up care. 
 
Methods 
Data and Study Population 
This study used administrative data from Alabama’s stand-alone CHIP, “ALL Kids,” from 2013 
to 2016 to calculate the quality measure for follow-up after psychiatric hospitalizations. 
Throughout this time period, ALL Kids coverage was available in 12-month enrollment periods 
4 
 
to Alabama children 18 years and younger with family incomes between 100% and 300% of the 
federal poverty level (FPL). Annual premiums and copayments for services are determined by 
family income as a percentage of FPL. This study was approved by an Institutional Review 
Board. 
 
Construction of the FUH Measure 
We constructed the FUH measure according to the CMS technical specifications 
manual.18 This measure is stewarded by the National Committee for Quality Assurance 
and uses Healthcare Effectiveness Data and Information Set (HEDIS) value set 
specifications for diagnosis and procedure codes, providers, and revenue center codes 
(i.e. what hospital department performed the procedure). First, to calculate the 
denominator for this measure, children aged 6 to 18 with a qualifying hospital discharge 
for acute psychiatric conditions were identified based on the HEDIS value set. Then, all 
non-acute inpatient stays (based on HEDIS value sets) were excluded. Next, eligibility 
was confirmed based on continuous enrollment for at least 30 days from discharge. 
Finally, exclusions were made for any transfers or readmissions within 30 days if those 
events were nonacute inpatient stays or non-psychiatric diagnoses. Per measure 
specifications, all readmissions and transfers for psychiatric diagnoses within 30 days 
were combined into single episodes. The numerator was calculated for a follow-up visit 
within 7 days and 30 days. Qualifying follow-up visits required specific procedure codes 
for care from a mental health provider or outpatient visits to specified types of behavioral 





Enrollee characteristics were derived from ALL Kids administrative systems. Eligibility 
categories based on FPL and race/ethnicity were identified from self-reported information 
provided by enrollee families on the enrollment application. Categories corresponding to cost 
sharing group included “low fee” between 146% to 156% FPL, “fee” between 157% to 208% 
FPL, and “expansion” between 209% to 317% FPL. A fourth group of children, the “no fee” 
group were exempted from cost-sharing by federal criteria, such as Native American heritage. 
We grouped enrollees into three mutually exclusive race/ethnic categories: white, black, and 
other. Two geographic measures were considered. First, rural-urban residence was based on ZIP 
code of enrollment address categorized into Rural-Urban Commuting Area (RUCA) codes. 
Second, to serve as a proxy variable for proximity to care, we constructed a measure of mental 
health provider density within 25 miles from an enrollee’s residence and each provider’s practice 
address using the geodetic distance from centroid to centroid.  
To explore potential differences in follow-up related to unique characteristics of 
psychiatric conditions, index hospitalization primary diagnosis codes were combined into 
broader groupings of depression, mood disorders, behavioral disorders, bipolar disorder, 
psychosis, and an “other” category which included schizophrenia, autism, adjustment disorders, 
and all other diagnoses (appendix table 1). Length of stay for the index hospitalization was 
categorized as 0 to 3 days, 4 to 7 days, or 8 or more days.  
To understand specific components of the measure that were challenging to achieve, we 
calculated the number of enrollees who would have met the measure under two different measure 
specifications holding the denominator constant. First, we examined the impact of extending the 
follow-up window to 45- and 60-days post-discharge. Second, we recalculated the 30-day 
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measure with primary care visits and any health care visits within 30 days of discharge. 
For primary care visits, we investigated whether some type of follow-up care with a 
child’s primary care provider may have been substituted for measure-defined care (i.e. 
with a qualified mental health provider), which potentially could be a proxy measure of 
poor access to mental health providers. For the any health care visits, we considered any 
medical or dental claims (excluding pharmacy claims) paid during this time window to 
represent active use of health care services among enrollees.   
Finally, we identified enrollees with hospitalizations and ED visits in the months 
subsequent the psychiatric hospitalization. Among enrollees in the measure denominator, 
we identified a subset with at least 30 days of continuous enrollment before their 
psychiatric hospitalization and at least 120 days following discharge. Within the 120-day 
period, we identified psychiatric hospitalizations and ED visits consistent with HEDIS 
definitions and, separately, hospitalizations and ED visits for any reason. Comparison of 
this subset to the overall study population did not reveal substantive differences in any 
characteristics, however the subset on average was slightly older and of lower FPL 
(results available upon request). Given the magnitude of these differences, and 
adjustment for these characteristics in the models, we do not have evidence these 
differences resulted in biases affecting internal validity or generalizability.  
 
Statistical Analysis 
Bivariate comparisons of enrollee characteristics associated with receiving 
follow-up care were compared using χ2 tests. Multivariable comparisons were estimated 
with logit regression models controlling for all other characteristics. We report marginal 
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effects at the means, which represent the percentage point change in the likelihood of the 
outcome for each predictor, holding all other factors constant at the mean value.  
A sensitivity analysis was conducted to determine if a multi-level logit model was 
appropriate given the nesting of hospitalizations within hospitals. We observed 31 different 
hospitals, however 95% of discharges took place at 11 facilities. We recoded any hospital with 
less than 2.5% of observations into an “other” category representing 5% of observations. The 
multi-level modeling approach allowed us to partition the total variance in follow-up into 
individual and hospital-level components. From the intraclass correlation coefficient, hospital-
level variation explained just 3% of the total variation in follow-up within 7 days and 1% within 
30 days. Coefficients from covariates were consistent with single-level logit models. Thus, we 
opted to report single-level logit models with hospital fixed effects (i.e. dummy variables) and 
clustered standard errors accounting for repeated visits among enrollees. 
Separately, we estimated the association with meeting the follow-up measure at 30 days 
with the likelihood of having psychiatric hospitalizations or ED visits using logit regression with 
clustered standard errors to estimate marginal effects representing the percentage point change in 
likelihood, holding all other covariates constant at the mean. 
 
Results 
Between 2013 and 2016, 1,072 psychiatric hospitalizations among 866 enrollees met 
measure criteria for inclusion. Among those hospitalizations, 356 (33.2%) received follow-up 
with a mental health provider within 7 days and 566 (52.8%) within 30 days. The extension of 
time to 45 days or 60 days increased follow-up for 38 hospitalizations (3.5 percentage points) 
and 56 hospitalizations (5.2 percentage points), respectively. Among hospitalizations which 
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otherwise had no qualifying follow-up care, an additional 8 (0.7 percentage points) had a 
primary care visit. and 172 (23.4 percentage points) used any services.  
Characteristics of enrollees receiving follow-up within 7 days and 30 days are 
shown in Table 1. The second column from the left displays characteristics of all 
enrollees with psychiatric hospitalizations. Hospitalizations most commonly were among 
those aged 11-15 years (57.5%), female (57.6%), white (69.0%), urban (71.4%), and had 
a depression diagnosis (49.0%). The third column displays row percentages of enrollees 
who met the measure divided by the number of enrollees with that characteristic enabling 
comparison vis-à-vis overall follow-up proportion. Greater frequency of follow-up within 
7 days was among females (35.7%, p=0.05), other non-white/non-black race (42.2%, 
p=0.02), small rural residents (43.5%, p=0.05), primary diagnosis of depression (39.1%, 
p<0.001), and length of hospitalization 0-3 days (43.1%, p <0.001). Lower frequency of 
follow-up within 7 days was among black race (28.1%, p=0.02), bipolar diagnosis 
(20.7%, p=0.01), and length of hospitalization 8 or more days (22.9%, p<0.001). Finally, 
the fifth column displays factors associated with follow-up within 30 days. Increased 
frequency of follow-up included being female (55.9%, p=0.02), primary diagnosis of 
depression (58.5%, p=<0.001), and length of hospitalization 0-3 days (63.6%, p <0.001).  
Individual characteristics associated with the likelihood of receiving follow-up 
care within 7 and 30 days estimated from logit models and controlling for all other 
covariates are shown in Table 2. The largest effects of reduced likelihood of follow-up 
within 7 days of discharge was observed for hospital length of stay, followed by age, and 
diagnosis. Hospital stays of 8 days or greater lowered the likelihood of follow-up by 18 
percentage points relative to stays of 3 days or fewer (p<0.001). Children aged 11-15 
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years were 13 percentage points less likely to receive follow-up compared to those 6-10 years 
old (p=0.03). Children with hospitalizations for mood disorders were 9 percentage points less 
likely to receive follow-up than children hospitalized for depression (p=0.02). The largest effects 
of increased likelihood of follow-up within 7 days was observed for hospitalizations in 2014 
relative to 2013 (9 percentage points, p=0.03). This was followed by the effect on children who 
identified as being non-white or non-black race/ethnicity compared to whites, which had an 
increased likelihood of 9 percentage points (p=0.02). Characteristics with statistically significant 
associations with the likelihood of follow-up within 30 days were fewer than observed for 
follow-up within 7 days, with only length of stay falling within conventional thresholds. 
Children hospitalized for 8 days or more were 26 percentage points less likely to receive follow-
up within 30 days than with hospitalizations of 3 days or fewer (p <0.001). 
Among 745 index hospitalizations wherein enrollees had a minimum of 30 days 
continuous enrollment prior to admission and 120 days post-discharge, the proportion with 
subsequent ED and hospitalizations is shown in Table 3. The majority of hospitalizations were 
psychiatric. Enrollees with follow-up care had lower frequencies of subsequent hospital and ED 
utilization, although many differences were not statistically significant at conventional levels. A 
statistically significant association was observed for psychiatric hospitalizations within 60 days 
of discharge; 3.0% of enrollees with follow-up care were re-hospitalized compared to 6.0% 
without follow-up care (p=0.05).  
The estimated likelihoods of subsequent ED visits are shown in Table 4, hospitalizations 
in Table 5. After controlling for all covariates, having follow-up care was associated with 
reduced likelihood of subsequent psychiatric hospitalizations and ED visits ranging between 2 
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and 4 percentage points. However, statistical significance was not observed in the fully 
adjusted models.  
 
Discussion 
The receipt of timely follow-up care after psychiatric hospitalization is low. Based 
on measure specifications, approximately half of hospitalizations received qualifying 
follow-up care within 30 days of discharge. Prior studies have consistently observed 
lower-than-optimal rates of follow-up among individuals, but comparisons are difficult to 
interpret given differences in populations by age, diagnosis, health insurance coverage 
(i.e. Medicaid, private, etc), and inconsistent follow-up care specifications.10-12,14-17,19,20 
National performance on this measure is highly variable and comparability across states 
and programs is difficult to ascertain.21,22 Differences between Medicaid and CHIP 
notwithstanding, some CHIPs report only on fee-for-service enrollees, while others 
include managed care or specific administrative subpopulations. Furthermore, while 
many states utilize External Quality Review Organizations,23 no single entity calculates 
performance across all state programs and therefore it is conceivable that differences in 
performance could be explained by interpretations of the measure, coding or billing 
practices, administrative subpopulation definitions, or other factors. We did not observe 
follow-up care sensitive to the measure definitions of timing or mental health provider 
criteria. Notably, we observed a sizeable proportion of enrollees without follow-up care 
who utilized services within 30 days of discharge, evidence they were active in the health 




 Hospitalization length of stay was the only consistent factor associated with receipt of 
follow-up care within 7 and 30 days after controlling for covariates. Age and hospitalization 
primary diagnosis groups were associated only with follow-up in 7 days. We did not observe 
effects by hospital, provider density, geographic setting, cost-sharing strata, or race; all of which 
were hypothesized based on findings from other studies.10-12,14-17,19,20 However, differences could 
be attributable to studies focused only on adults,12,15 Medicaid recipients,16,19 ED visits (rather 
than hospitalizations),15 or disease-specific cohorts.17,20 We also did not see large differences in 
performance over time, despite the growing national emphasis on quality measurement following 
the Children’s Health Insurance Program Reauthorization Act of 2009 and release of the initial 
Child Core Set technical specifications in February 2011, just two years before the study 
period.24 Prior studies have noted differences in follow-up care based on diagnosis. Compared to 
hospitalizations for depression, we observed all other diagnoses received follow-up care less 
often. Depression diagnoses were the most common among all hospitalizations we observed, and 
the findings may reflect specific challenges of different conditions. Specifically, we observed 
depression hospitalizations tended to have shorter lengths of stay (results available upon 
request), while other diagnoses such as bipolar disorder and psychosis had longer durations. 
Additionally, because the HEDIS measure definition uses administrative claims data, it is not 
sensitive to characteristics of conditions, such as self-harm or suicidal behavior. This could 
influence follow-up both on the patient and provider side, consistent with the hypothesis that 
those with more severe illness are more likely to follow-up.20 However, we observed longer 
length of stay reduces the likelihood of follow-up, which may be counter-intuitive to the severity 
hypothesis and requiring of future investigation. For example, analyses with greater numbers of 
hospitalizations than we observed could parse out complex interactions between diagnosed 
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conditions and the hospital length of stay. Likewise, more detailed information on disease 
characteristics/severity may enable a greater understanding of the unique challenges to follow-up 
care above and beyond diagnosis and the length of stay.   
 Although modest in the absolute effect size, there appears to be a consistent benefit of 
receiving timely follow-up care in the reduction of subsequent psychiatric hospitalization. We 
observed subsequent hospitalizations and ED visits for psychiatric conditions to occur 
infrequently; the observed risk was between 4.4% and 10.6% in our population. Follow-up care 
was associated with large relative effects—in the case of reducing psychiatric hospitalizations 
within 60 days, the relative difference was 50% lower for children with follow-up care. While 
timeliness is important to ensure patients are stabilized and have a successful transition home, 
reducing subsequent hospitalizations may also be an indicator of linkage to stable outpatient 
treatment, improved disease management, or more efficient use of health services. We observed 
fewer subsequent hospitalizations for enrollees receiving follow-up care but adjusting for 
covariates attenuated this association. Perhaps surprisingly, evidence in the scientific literature 
showing follow-up care has a demonstrable reduction in readmissions, subsequent 
hospitalizations, and ED visits is equivocal. While some studies of Medicaid recipients observed 
outpatient follow-up reduced psychiatric readmissions,11,12 a systematic review by Daniel et al25 
did not find consistent evidence of a benefit of follow-up care and subsequent studies had similar 
conclusions.10,16,17 This counterintuitive observation may reflect variations in the quality follow-
up care, or unmeasured disease severity.26 Repeated use of high acuity services, like 
hospitalizations and ED visits, for psychiatric care is a complex phenomenon, with many 
contributing demographic and clinical factors.27 A strong and consistent predictor of repeated 
hospitalizations and ED visits is having a prior psychiatric hospitalization or ED visit.27-29 Thus, 
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follow-up care in the outpatient setting may reduce the reliance of the ED in the continuum of 
care for psychiatric care.28 Despite the modest associations between follow-up care and 
subsequent hospitalizations and ED visits, quality improvement efforts could aim to enhance the 
effectiveness of outpatient follow-up care. . Furthermore, challenges and gaps to measuring 
quality of care remain, particularly for psychiatric care.30-33 Our analyses highlight potential 
long-term effects (i.e. reduced psychiatric hospitalizations and ED visits) that routine 
measurement may miss. Thus, mental health quality measures should continue to be re-evaluated 
and continuously improved.   
 Our findings must be interpreted along with some limitations. Notably, the HEDIS 
measure we used is designed for administrative claims data, which is limited in the ability to 
capture all sociodemographic factors, including parent/caregiver decisions and/or other barriers 
to care. We attempted to address this limitation by controlling for multiple covariates, but 
unmeasured confounding is possible. Furthermore, administrative data cannot capture all 
potential benefits of follow-up care, such as qualitative assessment of “smooth transitions” or 
quality of life.  Our study period coincided with the start of guidance from CMS to voluntarily 
track and report quality measures which are updated annually, and likewise coding/billing 
practices may have changed resulting in missing information about follow-up care. Finally, the 
generalizability beyond hospitalizations within Alabama’s CHIP may be limited, particularly in 
states with greater or lesser availability of community-based mental health services/providers, or 
among children with different family income ranges. It is possible that factors associated with 
utilization may differ in other states than that observed in Alabama, as well as the outcomes 





Opportunities to increase follow-up care after psychiatric hospitalizations exist within Alabama 
and nationally, as many states report low percentages. We did not observe follow-up rates 
sensitive to measurement definitions. We identified a limited influence by modifiable 
characteristics. While psychiatric conditions are complex and individual patients may present 
unique challenges, we observed conditions other than depression as well as longer length of stay 
associated with reduced follow-up, suggesting these patients are especially challenging. We 
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Table 1. Enrollee characteristics and rates of follow-up after psychiatric hospitalization within 7 










 N (%) 1,072 356 (33.2)  566 (52.8)  
Age 6-10 years 87 (8.1)   29 (33.3) 0.41   46 (52.9) 0.64 
Age 11-15 years 616 (57.5) 195 (31.7)  318 (51.6)  
Age 16-19 years 369 (34.4) 132 (35.8)  202 (54.7)  
Male 455 (42.4) 136 (29.9) 0.05 221 (48.6) 0.02 
Female 617 (57.6) 220 (35.7)  345 (55.9)  
White 740 (69.0) 241 (32.6) 0.02 383 (51.8) 0.12 
Black 178 (16.6)   50 (28.1)    90 (50.6)  
Other 154 (14.4)   65 (42.2)    93 (60.4)  
Cost-sharing Group      
     Low Fee  323 (30.1) 115 (35.6) 0.49 171 (52.9) 0.81 
     Fee  453 (42.3) 152 (33.6)  245 (54.1)  
     Expansion 287 (26.8)   87 (30.3)  146 (50.9)  
     Exempt     9 (  0.8)     2 (22.2)      4 (44.4)  
Rural-Urban Commuting Area      
     Urban 765 (71.4) 243 (31.8) 0.05 400 (52.3) 0.21 
     Large Rural  124 (11.6)   36 (29.0)    61 (49.2)  
     Small Rural   115 (10.7)   50 (43.5)    69 (60.0)  
     Isolated     65 (  6.1)   25 (38.5)    33 (50.8)  
     Unknown       3 (  0.3)     2 (66.7)        3 (100.0)  
Mental Health Providers within 
25 miles 
     
     0-42 277 (25.8)   89 (32.1) 0.27 135 (48.7) .44 
     43-108 264 (24.6)   98 (37.1)  146 (55.3)  
     109-232 268 (25.0)   92 (34.3)  145 (54.1)  
     233 or more 263 (24.5)   77 (29.3)  140 (53.2)  
Primary Diagnosis Group      
     Depression 525 (49.0) 205 (39.1) <0.001 306 (58.5) <0.001 
     Mood Disorder 196 (18.3)   55 (18.3) 0.09   96 (49.0) 0.24 
     Behavior Disorder 149 (13.9)   41 (27.5) 0.11   71 (47.7) 0.18 
     Bipolar Disorder   82 (  7.7)   17 (20.7) 0.01   34 (41.5) 0.03 
     Adjustment Disorder   44 (  4.1)   14 (31.8)  0.84   22 (50.0) 0.70 
     Psychosis   36 (  3.4)   13 (36.1) 0.71   20 (55.6) 0.74 
     Other   40 (  3.7)   11 (27.5) 0.43   17 (42.5) 0.18 
Hospital Length of Stay      
     0-3 days 209 (19.5)   90 (43.1) <0.001 133 (63.6) <0.001 
     4-7 days 548 (51.1) 194 (35.4)  322 (58.8)  
     8 or more days 315 (29.4)   72 (22.9)  111 (35.2)  
2013 383 (35.7) 117 (30.6) 0.09 205 (53.5) 0.28 
2014 239 (22.3)   95 (39.8)  137 (57.3)  
2015 215 (20.1)   66 (30.7)  109 (50.7)  
2016 235 (21.9)   78 (33.2)  115 (48.9)  
Note: p-value based on χ2 test. 
†Row percentages shown in parentheses (n with characteristic who meet the measure / n all with characteristic * 
100), which is interpreted as rate of follow-up among those with that characteristic.  
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Table 2. Adjusted likelihood meeting follow-up after psychiatric hospitalization measure at 7 and 
30 days (N=1,072) for enrollee characteristics. 
 
Likelihood of 
follow-up within 7 
days p-value 
Likelihood of 
follow-up within 30 
days p-value 
Age 6-10 years Reference  Reference  
Age 11-15 years -0.13 (-0.24, -0.01) 0.03 -0.10 (-0.21, 0.01) 0.07 
Age 16-19 years -0.09 (-0.21, 0.03) 0.13 -0.07 (-0.19, 0.04) 0.22 
Female 0.01 (-0.05, 0.07) 0.67 0.03 (-0.03, 0.10) 0.27 
White Reference  Reference  
Black -0.05 (-0.12, 0.02) 0.19 -0.04 (-0.12, 0.04) 0.31 
Other 0.09 (0.01, 0.17) 0.02 0.08 (-0.01, 0.16) 0.06 
Cost-sharing Group     
     Low Fee  Reference  Reference  
     Fee  -0.05 (-0.13, 0.02) 0.16 0.02 (-0.06, 0.09) 0.66 
     Expansion -0.08 (-0.16, 0.01) 0.06 -0.01 (-0.09, 0.08) 0.95 
     Exempt -0.25 (-0.46, -0.03) 0.03 -0.18 (-0.46, 0.10) 0.21 
Rural-Urban Commuting 
Code 
    
     Urban Reference  Reference  
     Large Rural -0.01 (-0.10, 0.09) 0.99 0.03 (-0.08, 0.14) 0.63 
     Small Rural 0.09 (-0.01, 0.20) 0.09 0.10 (-0.01, 0.21) 0.07 
     Isolated 0.09 (-0.05, 0.23) 0.19 0.04 (-0.10, 0.18) 0.56 
Mental Health Providers 
within 25 miles 
    
     0-42 Reference  Reference  
     43-108 0.05 (-0.04, 0.13) 0.27 0.06 (-0.04, 0.15) 0.23 
     109-232 0.04 (-0.06, 0.14) 0.43 0.07 (-0.04, 0.17) 0.22 
     233 or more -0.01 (-0.11, 0.09) 0.79 0.07 (-0.04, 0.19) 0.22 
Primary Diagnosis Group     
     Depression Reference  Reference  
     Mood Disorder -0.09 (-0.17, -0.01) 0.02 -0.07 (-0.16, 0.01) 0.08 
     Behavior Disorder -0.09 (-0.19, -0.01) 0.04 -0.07 (-0.16, 0.02) 0.14 
     Bipolar Disorder -0.11 (-0.23, 0.01) 0.07 -0.08 (-0.19, 0.04) 0.20 
     Adjustment Disorder -0.03 (-0.18, 0.12) 0.68 -0.02 (-0.17, 0.14) 0.84 
     Psychosis 0.07 (-0.09, 0.22) 0.39 0.05 (-0.11, 0.21) 0.56 
     Other -0.06 (-0.20, 0.08) 0.43 -0.07 (-0.23, 0.09) 0.37 
Hospital Length of Stay     
     0-3 days Reference  Reference  
     4-7 days -0.06 (-0.14, 0.02) 0.15 -0.03 (-0.11, 0.05) 0.50 
     8 or more days -0.18 (-0.26, -0.10) <0.001 -0.26 (-0.35, -0.17) <0.001 
2013 Reference  Reference  
2014 0.09 (0.01, 0.17) 0.03 0.03 (-0.05, 0.12) 0.48 
2015 0.02 (-0.06, 0.10) 0.69 -0.02 (-0.11, 0.07) 0.70 
2016 0.04 (-0.05, 0.12) 0.37 -0.04 (-0.13, 0.06) 0.43 
Note: Estimates from logit regression, model also contains hospital fixed effects and standard 




Table 3. Subsequent hospitalizations and emergency department (ED) utilization 60, 90, and 120 
days after index psychiatric hospitalization discharge, stratified by receipt of follow-up care 
within 30 days. 
 All (N=745) 
No follow-











Psychiatric hospitalization within 60 days 33 (4.4%) 21 (6.0%) 12 (3.0%) 3.0 50% 0.05 
Psychiatric hospitalization within 90 days 55 (7.4%) 30 (8.6%) 25 (6.3%) 2.3 27% 0.23 
Psychiatric hospitalization within 120 
days 79 (10.6%) 45 (12.9%) 34 (8.6%) 4.3 33% 0.06 
Any hospitalization within 60 days 35 (4.7%) 22 (6.3%) 13 (3.3%) 3.0 48% 0.05 
Any hospitalization within 90 days 60 (8.1%) 32 (9.2%) 28 (7.1%) 2.1 23% 0.29 
Any hospitalization within 120 days   85 (11.4%) 49 (14.0%) 36 (9.1%) 4.9 35% 0.03 
       
Psychiatric ED within 60 days 39 (5.2%) 23 (6.6%) 16 (4.0%) 2.6 39% 0.12 
Psychiatric ED within 90 days 52 (7.0%) 30 (8.6%) 22 (5.6%) 3.0 35% 0.10 
Psychiatric ED within 120 days 67 (9.0%) 38 (10.9%) 29 (7.3%) 3.6 28% 0.09 
Any ED within 60 days 93 (12.5%) 52 (14.9%) 41 (10.4%) 4.5 30% 0.06 
Any ED within 90 days 136 (18.3%) 73 (20.9%) 63 (15.9%) 5.0 24% 0.08 
Any ED within 120 days 169 (22.7%) 86 (24.6%) 83 (22.7%) 1.9    8% 0.23 
Note: p-value based on χ2 test. Absolute differences are reported in percentage points, relative 




Table 4. Likelihood of psychiatric hospitalizations visits 60, 90, and 120 days after index 
psychiatric hospitalization discharge (N=745) associated with receipt of follow-up care within 30 
days, controlling for covariates. 
 Likelihood of Psychiatric Emergency Department Visit 
Within 60 days  
(95% CI) p-value 
Within 90 days 
(95% CI) p-value 
Within 120 days 
(95% CI) p-value 
Follow-up within 30 days -0.03 (-0.06, 0.01) 0.11 -0.02 (-0.05, 0.02) 0.46 -0.02 (-0.07, 0.02) 0.32 
       
Age 6-15 years Reference  Reference  Reference  
Age 16-19 years -0.01 (-0.05, 0.02) 0.44 -0.01 (-0.05, 0.04) 0.70 -0.03 (-0.08, 0.02) 0.26 
Female  0.04 (-0.01, 0.08) 0.08 0.01 (-0.03, 0.06) 0.55 -0.03 (-0.04, 0.07) 0.26 
White Reference  Reference  Reference  
Black -0.01 (-0.04, 0.04) 0.98 0.01 (-0.05, 0.06) 0.74 0.01 (-0.06, 0.08) 0.76 
Other -0.01 (-0.05, 0.05) 0.94 -0.02 (-0.07, 0.03) 0.37 -0.03 (-0.09, 0.02) 0.26 
Cost-sharing Group       
     Low Fee  Reference  Reference  Reference  
     Fee  -0.02 (-0.06, 0.02) 0.27 -0.03 (-0.09, 0.03) 0.325 -0.05 (-0.12, 0.02) 0.21 
     Expansion -0.02 (-0.07, 0.03) 0.39 -0.01 (-0.07, 0.05) 0.69 -0.03 (-0.11, 0.04) 0.41 
     Exempt  0.12 (-0.11, 0.34) 0.32 0.35 (-0.01, 0.71) 0.06 0.33 (-0.01, 0.67) 0.06 
Rural-Urban Commuting 
Area 
      
     Urban Reference  Reference  Reference  
     Large Rural 0.03 (-0.03, 0.09) 0.30 0.05 (-0.01, 0.12) 0.12 0.04 (-0.05, 0.12) 0.37 
     Small Rural -0.01 (-0.05, 0.04) 0.84 0.01 (-0.06, 0.07) 0.85 -0.01 (-0.08, 0.05) 0.68 
     Isolated -0.02 (-0.06, 0.03) 0.50 0.04 (-0.06, 0.14) 0.44 0.05 (-0.06, 0.16) 0.38 
Primary Diagnosis Group       
     Depression Reference  Reference  Reference  
     Mood Disorder 0.01 (-0.04, 0.06) 0.72 -0.01 (-0.07, 0.06) 0.85 -0.03 (-0.10, 0.05) 0.49 
     Behavior Disorder 0.01 (-0.05, 0.05) 0.93 -0.01 (-0.08, 0.05) 0.64 -0.02 (-0.10, 0.05) 0.54 
     Bipolar Disorder 0.02 (-0.04, 0.08) 0.50 0.07 (0.01, 0.13) 0.05 0.07 (-0.01, 0.15) 0.07 
     Adjustment Disorder 0.01 (-0.10, 0.10) 0.98     
     Psychosis 0.02 (-0.07, 0.11) 0.62 0.04 (-0.05, 0.12) 0.40 -0.01 (-0.12, 0.12) 0.97 
     Other 0.09 (0.03, 0.14) <0.01 0.10 (0.03, 0.17) 0.005 0.10 (0.02, 0.19) 0.02 
Hospital Length of Stay       
     0-3 days Reference  Reference  Reference  
     4-7 days -0.03 (-0.08, 0.03) 0.31 -0.03 (-0.08, 0.03) 0.38 -0.01 (-0.07, 0.05) 0.80 
     8 or more days -0.04 (-0.10, 0.02) 0.23 -0.01 (-0.07, 0.06) 0.88 0.02 (-0.05, 0.09) 0.57 



















Table 5. Likelihood of psychiatric emergency department (ED) visits 60, 90, and 120 days after 
index psychiatric hospitalization discharge (N=745) associated with receipt of follow-up care 
within 30 days, controlling for covariates. 
 
 
Likelihood of Psychiatric Hospitalization 
Within 60 days p-value Within 90 days p-value Within 120 days p-value 
Follow-up within 30 days -0.03 (-0.07, 0.01) 0.11 -0.03 (-0.07, 0.01) 0.14 -0.04 (-0.08, 0.01) 0.11 
       
Age 6-15 years Reference  Reference  Reference  
Age 16-19 years -0.03 (-0.06, -
0.01) 
0.04 -0.01 (-0.05, 0.03) 0.50 -0.01 (-0.06, 0.03) 0.54 
Female 0.04 (0.01, 0.08) 0.04 0.05 (0.01, 0.09) 0.04 0.05 (0.01, 0.10) 0.04 
White Reference  Reference  Reference  
Black -0.01 (-0.05, 0.04) 0.70 0.01 (-0.05, 0.06) 0.79 0.01 (-0.06, 0.06) 0.92 
Other -0.02 (-0.06, 0.02) 0.38 -0.01 (-0.07, 0.04) 0.60 -0.03 (-0.08, 0.03) 0.37 
Cost-sharing Group       
     Low Fee  Reference  Reference  Reference  
     Fee  -0.02 (-0.07, 0.03) 0.37 -0.02 (-0.07, 0.03) 0.38 -0.02 (-0.08, 0.03) 0.41 
     Expansion -0.01 (-0.07, 0.04) 0.58 0.01 (-0.06, 0.07) 0.84 0.02 (-0.05, 0.09) 0.63 
     Exempt 0.38 (-0.02, 0.78) 0.06 0.48 (0.03, 0.93) 0.04 0.50 (0.07, 0.94) 0.02 
Rural-Urban Commuting 
Area 
      
     Urban Reference  Reference  Reference  
     Large Rural 0.01 (-0.05, 0.08) 0.66 0.02 (-0.05, 0.10) 0.56 0.01 (-0.06, 0.09) 0.73 
     Small Rural -0.03 (-0.07, 0.01) 0.05 -0.05 (-0.09, -
0.01) 
0.007 -0.07 (-0.11, -0.03) <0.001 
     Isolated 0.01 (-0.07, 0.08) 0.94 -0.02 (-0.09, 0.06) 0.64 0.01 (-0.10, 0.13) 0.86 
Primary Diagnosis Group       
     Depression Reference  Reference  Reference  
     Mood Disorder 0.02 (-0.03, 0.06) 0.40 -0.01 (-0.05, 0.05) 0.94 -0.01 (-0.07, 0.04) 0.72 
     Behavior Disorder 0.01 (-0.03, 0.06) 0.54 -0.01 (-0.07, 0.05) 0.74 -0.04 (-0.11, 0.03) 0.32 
     Bipolar Disorder 0.01 (-0.06, 0.07) 0.78 0.03 (-0.04, 0.10) 0.43 0.05 (-0.04, 0.12) 0.24 
     Adjustment Disorder 0.03 (-0.04, 0.11) 0.42 0.01 (-0.09, 0.10) 0.938 0.05 (-0.04, 0.14) 0.32 
     Psychosis 0.01 (-0.09, 0.12) 0.80 -0.02 (-0.15, 0.11) 0.78 -0.05 (-0.22, 0.11) 0.54 
     Other -0.01 (-0.10, 0.10)  0.98 -0.04 (-0.17, 0.09) 0.57 -0.07 (-0.24, 0.09) 0.39 
Hospital Length of Stay       
     0-3 days Reference  Reference  Reference  
     4-7 days -0.03 (-0.08, 0.02) 0.27 -0.03 (-0.04, 0.06) 0.33 -0.03 (-0.09, 0.03) 0.33 
     8 or more days -0.05 (-0.11, 0.01) 0.08 -0.03 (-0.10, 0.03) 0.31 -0.04 (-0.11, 0.03) 0.25 
Note: Models also control for year. Standard errors are clustered for repeated observations among 
enrollees. 
 
 
